Use of Lidocaine in Rapid Sequence Induction

Hemodynamic Response Clinical Trial

Official title:
Impact of Lidocaine on Anesthetic Depth During Rapid Sequence Induction

Status Completed

Clinical Trial Summary

Lidocaine has been shown to blunt the cardiovascular response to endotracheal intubation. The incidence of hypertension, tachycardia and dysrhythmias due to laryngoscopy may be increased in patients that receive rapid sequence induction and intubation, where opioids are spared and intravenous anesthetic agents are not titrated step by step. Our hypothesis was that lidocaine when administered intravenously in patients who undergo rapid sequence induction may not only blunt the hemodynamic response to intubation, but may also increase the anesthetic depth (as assessed by BIS), thus further reducing the possibility of hypertension, arrhythmias and also awareness.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hemodynamic Response

Clinical Trial Details

NCT number	NCT01238718
Study type	Interventional
Source	University of Athens
Contact
Status	Completed
Phase	N/A
Start date	October 2008
Completion date	July 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03077503` - Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application	Phase 4
Completed	`NCT05238506` - Lidocaine VS Hemodynamic, Metabolic and Hormonal Response	Phase 4
Terminated	`NCT03540147` - The Impact of Blood Flow Restriction (BFR) on Exercise and Hemodynamic Responses	N/A